RenovoRx Highlights Peer-Reviewed Publication Supporting Intra-Arterial Gemcitabine Delivery Via TAMP™ in Locally Advanced Pancreatic Cancer
RenovoRx Inc RNXT
$0.92
▲ +3.29%
(+$0.03)
Open
$0.91
Prev Close
$0.89
Day Range
$0.89 – $0.94
52W Range
$0.70 – $1.45
Market Cap
$41.45M
Beta
0.93
EPS (TTM)
$-0.33
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-08-17 |
| Shares Out. | 45,050,000 |
| Website | renovorx.com/ ↗ |
| Phone | 14088002649 |
RenovoRx Inc is a publicly traded company under the ticker symbol RNXT on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-06-01)